These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27789974)

  • 1. Nationwide trends in glucose-lowering drug use, Denmark, 1999-2014.
    Christensen DH; Rungby J; Thomsen RW
    Clin Epidemiol; 2016; 8():381-387. PubMed ID: 27789974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antidiabetic drug utilization and expenditure in Denmark: A 22-year nationwide study.
    Bang C; Mortensen MB; Lauridsen KG; Bruun JM
    Diabetes Obes Metab; 2020 Feb; 22(2):167-172. PubMed ID: 31486269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups.
    Csatordai M; Benkő R; Matuz M; Bor A; Lengyel C; Doró P
    Diabet Med; 2019 Dec; 36(12):1612-1620. PubMed ID: 31456231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018.
    Shao H; Laxy M; Benoit SR; Cheng YJ; Gregg EW; Zhang P
    Diabetes Care; 2021 Apr; 44(4):925-934. PubMed ID: 33563653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the incidence of use of noninsulin glucose-lowering drugs between 2006 and 2013 in France.
    Arnaud M; Bezin J; Bégaud B; Pariente A; Salvo F
    Fundam Clin Pharmacol; 2017 Dec; 31(6):663-675. PubMed ID: 28575541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016.
    Zhao JZ; Weinhandl ED; Carlson AM; St Peter WL
    Kidney Med; 2021; 3(2):173-182.e1. PubMed ID: 33851113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and regional differences in antidiabetic medication use: a nationwide retrospective observational study.
    Csatordai M; Benkő R; Matuz M; Engi Z; Csupor D; Lengyel C; Doró P
    Diabetol Metab Syndr; 2024 Apr; 16(1):88. PubMed ID: 38658983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies.
    Adelborg K; Grove EL; Sundbøll J; Laursen M; Schmidt M
    Heart; 2016 Dec; 102(23):1883-1889. PubMed ID: 27406838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
    van Baar MJB; van Ruiten CC; Muskiet MHA; van Bloemendaal L; IJzerman RG; van Raalte DH
    Diabetes Care; 2018 Aug; 41(8):1543-1556. PubMed ID: 30030256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus.
    Shin JI
    Curr Diab Rep; 2019 Jul; 19(8):54. PubMed ID: 31286271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Incidence of Medication-Treated Diabetes and Pattern of Glucose-Lowering Treatment During the COVID-19 Pandemic: Real-World Data from the Electronic Greek Prescription Database.
    Siafarikas C; Karamanakos G; Makrilakis K; Tsolakidis A; Mathioudakis K; Liatis S
    Exp Clin Endocrinol Diabetes; 2024 Jun; ():. PubMed ID: 38626912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seventeen-Year Nationwide Trends in Antihypertensive Drug Use in Denmark.
    Sundbøll J; Adelborg K; Mansfield KE; Tomlinson LA; Schmidt M
    Am J Cardiol; 2017 Dec; 120(12):2193-2200. PubMed ID: 29054274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective.
    Thompson PL; Davis TME
    Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study.
    Kristensen KB; Karlstad Ø; Martikainen JE; Pottegård A; Wastesson JW; Zoega H; Schmidt M
    Pharmacotherapy; 2019 Feb; 39(2):150-160. PubMed ID: 30636337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
    Ferrannini E; DeFronzo RA
    Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy.
    Larsen J; Vaccheri A; Andersen M; Montanaro N; Bergman U
    Br J Clin Pharmacol; 2000 May; 49(5):463-71. PubMed ID: 10792204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.